-
Journal of Asthma and Allergy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Childhood asthma and anthropogenic CO2 emissions
Editorial
(1602) Views (331) Full article downloads
Authors: Dosanjh A
Published Date October 2011
Volume 2011:4 Pages 103 - 105
DOI: http://dx.doi.org/10.2147/JAA.S24565
Amrita Dosanjh
Pediatric Pulmonologist, San Diego, California, USA
Trends in the incidence of childhood asthma worldwide have paralleled the sharp increase in carbon dioxide (CO2) emissions, over at least the last two decades. The prevalence of asthma in the United States has quadrupled over the last 20 years in part due to climate-related factors. In a report released by Harvard Medical School and the Center for Health and the Global Environment, it was noted that there was an increase in asthma incidence of 160% from 1980–1994 among preschool children.
Readers of this article also read:
Immunological and genetic aspects of asthma and allergy
New therapies and management strategies in the treatment of asthma: patient-focused developments
Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD
Update on optimal use of omalizumab in management of asthma
Clinical update on the use of biomarkers of airway inflammation in the management of asthma
Successful treatment of reactive airways dysfunction syndrome by high-dose vitamin D
Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease
The impact of vitamin D deficiency on immune T cells in asthmatic children: a case-control study
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




